Powered by

Altria Group Invests Up to $12M in Lexaria Bioscience's DehydraTECH„¢ Technology

Jan 17, 2019 - GlobeNewswire
Mergers and Acquisitions-Investments

KELOWNA, British Columbia, Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Lexaria Nicotine LLC, a wholly owned subsidiary of Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), has entered into a definitive agreement with Altria Group Inc. (NYSE: MO) to fund the research & development of Lexaria's patented DehydraTECH„¢ technology.

Lexaria's DehydraTECH„¢ enhances the performance of beneficial compounds in ingestible products across four categories: taste & smell, speed of ac...